| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0033 | 1 |